Debut Plus

₹437

▼ -3.7 -0.84%

18 Jul 2026

BSE Listed · Pharmaceuticals

Biocon Ltd. (532523)

Volume: 1,60,961Avg Vol 1W: 98,98,055Avg Vol 1M: 23,96,86152W Range:₹331₹447
BSE www.biocon.com
Key Ratios
Checked just now
Market Cap₹71,218 Cr
Current Price₹437
Previous Close₹440.7
High / Low (52w)₹447 / ₹331
Volume1,60,961
Avg Vol (1W)98,98,055
Avg Vol (1M)23,96,861
Stock P/E182.85
Book Value₹211.51
Dividend Yield11%
ROE114.44%
ROA57.94%
Revenue (TTM)—
Revenue Growth3.43%
Profit Margin229.8%
Total Debt₹12,405 Cr
Shares Outstanding163 Cr
Face Value₹5
EPS (TTM)₹2.39
P/B2.07
Debt / Equity0.84
50 DMA₹418.48
200 DMA₹386.3
Day change-0.84%
Price Chart
₹437▲ 10.12% · 1Y
₹441₹3394.8Cr
2025-07-17
2026-07-17

20-day avg volume: 26.3L shares

Pros
  • Healthy return on equity of 114.4%.
  • Pays a dividend yield of 11.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 183.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹3,433 Cr₹3,590 Cr₹3,821 Cr₹4,417 Cr₹3,942 Cr₹4,296 Cr₹4,173 Cr₹4,517 Cr
EBITDA₹1,350 Cr₹298 Cr₹361 Cr₹679 Cr₹374 Cr₹455 Cr₹436 Cr₹559 Cr
Net Profit₹660 Cr₹-16 Cr₹25 Cr₹345 Cr₹31 Cr₹85 Cr₹144 Cr₹126 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹5,659 Cr₹6,462 Cr₹7,398 Cr₹8,397 Cr₹11,550 Cr₹15,621 Cr₹16,470 Cr₹17,270 Cr
EBITDA₹1,090 Cr₹1,212 Cr₹1,192 Cr₹1,369 Cr₹1,775 Cr₹2,595 Cr₹2,688 Cr₹1,841 Cr
Net Profit₹905 Cr₹748 Cr₹741 Cr₹648 Cr₹463 Cr₹1,023 Cr₹1,013 Cr₹386 Cr
EPS7.66.36.195.423.878.548.462.82
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹12,192 Cr₹14,444 Cr₹18,522 Cr₹20,394 Cr₹52,043 Cr₹56,071 Cr₹58,797 Cr₹63,651 Cr
Total Liabilities₹5,486 Cr₹7,061 Cr₹10,015 Cr₹10,924 Cr₹29,554 Cr₹30,796 Cr₹31,085 Cr₹27,029 Cr
Equity₹6,707 Cr₹7,383 Cr₹8,508 Cr₹9,470 Cr₹22,489 Cr₹25,275 Cr₹27,713 Cr₹36,622 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1,446 Cr₹1,627 Cr₹1,354 Cr₹1,439 Cr₹2,081 Cr₹3,246 Cr₹4,521 Cr₹2,237 Cr
Investing₹-714 Cr₹-1,559 Cr₹-3,625 Cr₹-1,699 Cr₹-14,282 Cr₹-1,004 Cr₹-234 Cr₹-2,082 Cr
Financing₹-242 Cr₹388 Cr₹2,564 Cr₹242 Cr₹13,049 Cr₹-2,333 Cr₹-1,854 Cr₹-924 Cr
Free Cash Flow₹1,446 Cr₹1,627 Cr₹1,354 Cr₹1,439 Cr₹2,081 Cr₹3,246 Cr₹4,521 Cr₹2,237 Cr
Shareholding
Promoter 44.68% Institutions 30.09% Public 25.24%
Efficiency & Working Capital
ROCE3.6%
Interest Coverage1.8
Dividend Payout—
Debtor Days129 d
Inventory Days131 d
Payable Days146 d
Cash Conversion Cycle114 d
Working Capital Days260 d
Shareholding Details

As of 2026-06-30

Promoter44.7%
FII8.2%
DII21.9%
Institutions30.1%
Public25.2%
Promoter Pledge0%
No. of Shareholders3,92,509
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Jan 2026Jan 2026Mar 2026Jun 2026
Promoters60.6%60.6%60.6%60.6%60.6%54.5%54.5%54.5%44.9%44.9%44.9%44.7%
FIIs5.6%5.9%5.9%5.7%5.7%6%6.6%7.4%7.1%7.1%7.5%8.2%
DIIs13.7%14.3%14.4%15.4%15.7%22.8%22.1%21.7%24.2%24.2%24.1%21.9%
Public20.1%19.2%19%18.3%18%16.7%16.8%16.4%23.6%23.8%23.5%25.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders4,70,2614,43,5134,39,5034,27,7054,24,2974,28,1314,13,1913,94,2793,94,7593,94,7593,86,5933,92,509
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Kiran Mazumdar ShawShareholding of Promoter and Promoter Group29.7%48.46 Cr
Glentec InternationalShareholding of Promoter and Promoter Group14.6%23.72 Cr
Sbi Esg Exclusionary Strategy FundPublic Shareholding8.8%14.27 Cr
Mylan Inc.Public Shareholding5.6%9.20 Cr
Lici Ulip-growth FundPublic Shareholding3.7%6.10 Cr
Serum Institute Life Sciences Private LimitedPublic Shareholding3.4%5.54 Cr
Isif Equity Ex-top 100 Long-short FundPublic Shareholding1.5%2.38 Cr
Kotak Large & Midcap FundPublic Shareholding1.2%2.02 Cr
Activ Pine LlpPublic Shareholding1.1%1.77 Cr
Ravi Rasendra MazumdarShareholding of Promoter and Promoter Group0.3%53,58,440
Dev MazumdarShareholding of Promoter and Promoter Group0.1%9,29,721
Glenloch Properties LlpShareholding of Promoter and Promoter Group0%0
Mazumdar Shaw Medical FoundationShareholding of Promoter and Promoter Group0%0
Carica InvestmentShareholding of Promoter and Promoter Group0%0
JeevesShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Kiran Mazumdar Shaw00%2026-06-29
Glenloch Properties Llp00%2026-06-29
Mazumdar Shaw Medical Foundation00%2026-06-29
Carica Investment00%2026-06-29
Jeeves00%2026-06-29
Ravi Rasendra Mazumdar00%2026-06-29
Dev Mazumdar00%2026-06-29
Glentec International00%2026-06-29
Isif Equity Ex-top 100 Long-short Fund00%2026-06-29
Kotak Large & Midcap Fund00%2026-06-29
Sbi Esg Exclusionary Strategy Fund00%2026-06-29
Lici Ulip-growth Fund00%2026-06-29
Board of Directors
NameDesignationYear
Kiran Mazumdar ShawChairperson2025
Ravi MazumdarNon Executive Director2025
Bobby ParikhIndependent Director2025
Eric Vivek MazumdarNon Executive Director2025
Naina Lal KidwaiLead Independent Director2025
Atul DhawanIndependent Director2025
Rekha Mehrotra MenonIndependent Director2025
NICHOLAS ROBERT HAGGARIndependent Director2025
Ekta AgarwalCompany Sec. & Compli. Officer2025
Shreehas Pradeep TambeManaging Director & Chief Executive Officer2025
Segments — Geography
RegionRevenueShare
India₹890 Cr45.4%
Singapore₹153 Cr7.8%
Brazil₹148 Cr7.6%
Rest of the world₹769 Cr39.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹5900811811
Corporate Actions
TypeDateValueRemark
dividend2026-07-03₹0.5 (10.0%)Final
dividend2026-07-03₹0.5 (10%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253,784032573,819
20252,68900002,689
202533000033
Insider / Designated-Person Trades

30 recent disclosure(s)

SIVANANDAM K RevisedPledge · 7,328
NEHAL VORAPledge · 61,827
SIVANANDAM KPledge · 7,328
KIRAN KUMAR GANDHIRAJANDisposal · 19,998
AKHILESH NANDDisposal · 11,000
RAHUL AGRAWALAcquisition · 2,000
Substantial Acquisitions (SAST)

7 disclosure(s)

Market16/01/2026 · 3,34,70,117
Market11/11/2025 · 3,70,150
Market13/09/2024 · 5,00,000
Inter-se Transfer22/09/2023 · 84,45,348
Inter-se Transfer22/09/2023 · 84,45,348
Inter-se Transfer05/09/2022 · 8,97,475
Company Information
Incorporated1978
ChairmanKiran Mazumdar Shaw
AuditorB S R & Co LLP
Investor Email[email protected]
🌐 www.biocon.com ↗

📍 20th KM Hosur Road Hebbagodi, Electronic City P O, Bangalore, Karnataka, 560100

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Astra Microwave ProductsNavin Fluorine InternationalBAG Films & MediaJindal StainlessPalred TechnologiesPetronet LNGPTC IndiaDatamatics Global ServicesNew Delhi Television (NDTV)Strides Pharma ScienceUltraTech Cement Ltd.Tata Consultancy ServicesAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search